Geode Capital Management, LLC Nevro Corp Transaction History

Geode Capital Management, LLC

$1.12 Trillion
Q2 2024

A detailed history of Geode Capital Management, LLC transactions in Nevro Corp stock. As of the latest transaction made, Geode Capital Management, LLC holds 834,592 shares of NVRO stock, worth $4.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

834,592

Previous 800,528 4.26%

Holding current value

$4.82 Million

Previous $11.6 Million 39.21%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$7.96 - $13.59 $271,149 - $462,929	34,064 Added 4.26%	834,592 $7.03 Million
Q1 2024 May 13, 2024	BUY	$13.56 - $20.78 $432,225 - $662,362	31,875 Added 4.15%	800,528 $11.6 Million
Q4 2023 Feb 13, 2024	BUY	$14.18 - $22.31 $554,140 - $871,852	39,079 Added 5.36%	768,653 $16.5 Million
Q3 2023 Nov 13, 2023	BUY	$18.22 - $25.85 $507,773 - $720,413	27,869 Added 3.97%	729,574 $14 Million
Q2 2023 Aug 11, 2023	BUY	$22.62 - $39.32 $972,479 - $1.69 Million	42,992 Added 6.53%	701,705 $17.8 Million
Q1 2023 May 15, 2023	BUY	$30.17 - $41.11 $949,600 - $1.29 Million	31,475 Added 5.02%	658,713 $23.8 Million
Q4 2022 Feb 13, 2023	BUY	$36.43 - $49.4 $795,886 - $1.08 Million	21,847 Added 3.61%	627,238 $24.8 Million
Q3 2022 Nov 14, 2022	BUY	$40.66 - $53.03 $586,195 - $764,533	14,417 Added 2.44%	605,391 $28.2 Million
Q2 2022 Aug 12, 2022	SELL	$40.85 - $77.67 $375,003 - $713,010	-9,180 Reduced 1.53%	590,974 $25.9 Million
Q1 2022 May 13, 2022	BUY	$59.95 - $92.06 $1.69 Million - $2.6 Million	28,200 Added 4.93%	600,154 $43.4 Million
Q4 2021 Feb 11, 2022	BUY	$81.07 - $121.29 $814,996 - $1.22 Million	10,053 Added 1.79%	571,954 $46.4 Million
Q3 2021 Nov 12, 2021	SELL	$101.99 - $166.36 $2.11 Million - $3.44 Million	-20,695 Reduced 3.55%	561,901 $65.4 Million
Q2 2021 Aug 13, 2021	BUY	$141.6 - $179.06 $3.46 Million - $4.37 Million	24,410 Added 4.37%	582,596 $96.6 Million
Q1 2021 May 12, 2021	BUY	$132.81 - $182.18 $5.93 Million - $8.14 Million	44,675 Added 8.7%	558,186 $77.9 Million
Q4 2020 Feb 12, 2021	BUY	$138.17 - $184.34 $3.97 Million - $5.29 Million	28,714 Added 5.92%	513,511 $88.9 Million
Q3 2020 Nov 13, 2020	SELL	$114.09 - $145.51 $1.16 Million - $1.48 Million	-10,205 Reduced 2.06%	484,797 $67.5 Million
Q2 2020 Aug 13, 2020	BUY	$89.45 - $129.85 $4.8 Million - $6.97 Million	53,683 Added 12.16%	495,002 $59.1 Million
Q1 2020 May 14, 2020	BUY	$70.23 - $144.31 $2.5 Million - $5.14 Million	35,587 Added 8.77%	441,319 $44.1 Million
Q4 2019 Feb 13, 2020	BUY	$76.41 - $117.54 $2.04 Million - $3.13 Million	26,664 Added 7.03%	405,732 $47.7 Million
Q3 2019 Nov 12, 2019	BUY	$61.52 - $91.1 $634,148 - $939,058	10,308 Added 2.8%	379,068 $32.6 Million
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $1.64 Million - $1.9 Million	28,306 Added 8.31%	368,760 $23.9 Million
Q1 2019 May 14, 2019	BUY	$35.52 - $62.62 $1.12 Million - $1.97 Million	31,459 Added 10.18%	340,454 $21.3 Million
Q4 2018 Feb 13, 2019	BUY	$35.43 - $56.29 $933,793 - $1.48 Million	26,356 Added 9.32%	308,995 $12 Million
Q3 2018 Nov 13, 2018	BUY	$44.22 - $75.47 $804,892 - $1.37 Million	18,202 Added 6.88%	282,639 $16.1 Million
Q2 2018 Aug 14, 2018	BUY	$72.38 - $92.5 $1.67 Million - $2.13 Million	23,015 Added 9.53%	264,437 $21.1 Million
Q1 2018 May 15, 2018	BUY	$69.46 - $88.57 $384,738 - $490,589	5,539 Added 2.35%	241,422 $20.9 Million
Q4 2017 Feb 13, 2018	BUY	$65.94 - $93.31 $94,162 - $133,246	1,428 Added 0.61%	235,883 $16.3 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $3.85 Million - $4.34 Million	47,633 Added 25.5%	234,455 $21.3 Million
Q2 2017 Aug 14, 2017	BUY	N/A	186,822	186,822 $13.9 Million

Others Institutions Holding NVRO

# of Institutions

158

Shares Held

37.7M

Call Options Held

44K

Put Options Held

1.69M

View Full List

About NEVRO CORP

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $205M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

More about NVRO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Nevro Corp Transaction History